Sign in
Taking people in South KoreaNo phase

Leg blood-flow catheter placed routinely or only when needed during heart support

Compares routine versus as-needed leg catheter placement in people receiving mechanical heart support.

Key facts

Who runs it
Samsung Medical Center
Where
Changwon, Incheon, and Seoul, South KoreaSee the 6 sites
Trial code
Registry title
Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
Status
Recruiting
People taking part
500 people, planned
Started
8 Jul 2026
Expected to end
31 Oct 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Distal perfusion catheter insertion
Record updated
23 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults in cardiogenic shock who need a mechanical heart support device placed through the femoral artery. It compares routine versus provisional placement of a distal perfusion catheter.

Age
19 years or older
Sex
All sexes can join.
Disease stage
Cardiogenic shock that needs mechanical circulatory support through the femoral artery.
Earlier treatment
No previous femoral-femoral or femoral-popliteal bypass grafting.

Main reasons for not taking part

  • Clear signs of acute limb ischemia right after the support device is placed
  • Serious blood clotting problem that makes an invasive procedure too risky because of bleeding
  • Pregnant women, women who could have children, or women who are breastfeeding
  • Limb ischemia that cannot be reversed and needs a procedure or surgery when the device is placed
  • Previous limb amputation

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Patients aged 19 years old
  • Cardiogenic shock requiring mechanical circulatory support through femoral artery approach
  • Subject who can verbally confirm understandings of risks and benefits of receiving distal perfusion catheter insertion and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure
  • Under the critically-ill clinical circumstance (unclear consciousness of patient), legally authorized representative can provide written informed consent prior to any study related procedure

Who cannot take part

  • Irreversible limb ischemia requiring interventional procedures or surgery at the time of MCS insertion
  • Previous history if femoral-femoral bypass grafting or femoral-popliteal bypass grafting
  • Previous history of limb amputation
  • Significant coagulopathy precluding invasive procedure due to high risk of bleeding
  • Apparent symptoms and sign of acute limb ischemia immediately after mechanical circulatory support insertion
  • Pregnant women, women with potential childbearing, or lactating women
  • Unwilling or unable to obtain informed consent from the participant or legally authorized representative

Where in South Korea

  • Gyeongsang National University Changwon hospitalChangwon, South KoreaContact: Jong-Hwa Ahn, MD, PhDNot yet recruiting
  • Samsung Medical Center Changwon HospitalChangwon, South KoreaContact: Ik-Hyun Park, MD, PhDNot yet recruiting
  • Kwandong University Intl. ST. Mary's HospitalIncheon, South KoreaContact: Hyung-Bok Park, MD, PhDNot yet recruiting
  • Eunpyeong St. Mary's HospitalSeoul, South KoreaContact: Suk Min Seo, MD, PhDNot yet recruiting
  • Korea University Anam HospitalSeoul, South KoreaContact: Yonghoon Shin, MD, PhDNot yet recruiting
  • Samsung Medical CenterSeoul, South KoreaContact: Joo Myung Lee, MD, MPH, PhDTaking people

About the trial

What the trial wants to find out

A prospective, multi-center, open label, randomized controlled, superiority trial to compare clinical outcomes between routine distal perfusion catheter (DPC) insertion versus provisional distal perfusion catheter (DPC) insertion in the occurrence of sign or symptom of acute limb ischemia in patients undergoing mechanical circulatory support (MCS) through femoral artery approach.

The 2 groups in the trial

  • Routine distal perfusion catheter insertion groupTreatment being tested

    In the routine DPC insertion group, DPC insertion will be performed within 1 hour from MCS or from transfer from outside hospital under MCS. Fluoroscopy-guided DPC insertion will be used. In case of fluoroscopy is not available or patient's hemodynamic condition precludes transfer of patient to catheterization laboratory, bed-side ultrasound-guided DPC will be permitted.

    Treatment: Distal perfusion catheter insertion

  • Provisional distal perfusion catheter insertion groupExisting treatment, for comparison

    In the provisional distal perfusion catheter insertion group, DPC insertion will be performed at the time of symptom or sign of limb ischemia. Fluoroscopy-guided DPC insertion will be used. In case of fluoroscopy is not available or patient's hemodynamic condition precludes transfer of patient to catheterization laboratory, bed-side ultrasound-guided DPC will be permitted.

    Treatment: Distal perfusion catheter insertion

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support
Plain-language title
Leg blood-flow catheter placed routinely or only when needed during heart supportGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
23 October 2026